Data / Form D filings / Ambagon Therapeutics Inc.
Ambagon Therapeutics Inc.: Form D filings
Ambagon Therapeutics Inc., a biotechnology company in Eindhoven, Netherlands, filed 6 Form D notices with the SEC between 2020 and 2025. The latest, on February 7, 2025, reports $5 million sold of a $12 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- De Lismortel 31, Catalyst Business Ctr, Eindhoven, Netherlands, 5612
- Phone
- 31 40 7517694
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1819934
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | New notice | $12,000,000 | $5,000,000 | $7,000,000 | 4 | Jan 24, 2025 | sec.gov |
| Jun 1, 2022 | Amendment | $84,999,994 | $44,999,996 | $39,999,998 | 9 | Jan 5, 2022 | sec.gov |
| Jan 19, 2022 | New notice | $84,999,994 | $44,999,996 | $39,999,998 | 9 | Jan 5, 2022 | sec.gov |
| Dec 22, 2021 | Amendment | $5,399,998 | $5,399,998 | 8 | Dec 7, 2021 | sec.gov | |
| Aug 20, 2021 | Amendment | $5,399,998 | $5,399,998 | 8 | Jul 30, 2021 | sec.gov | |
| Aug 3, 2020 | New notice | $7,199,998 | $7,199,998 | 8 | Jul 17, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Melissa McCracken | Director | |
| Josh Seidenfeld | Executive Officer | |
| Christian Ottmann | Executive Officer |
Every Form D from the week of Feb 3, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ambagon Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.